510(k) Report

510(k) · Cleared

Cleared

T3 Platform software

K223578510(k) TraditionalCleared Jul 7, 2023219-day reviewClass II21 CFR 870.2200

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Etiometry, Inc. · PPW Adjunctive Cardiovascular Status Indicator

Cleared on Jul 7, 2023 as substantially equivalent to K213230 (Etiometry, Inc., 2022) after a 219-day review. Its family tree reaches back 13 generations to 1997. 2 later devices descend from it.

Decided
Jul 7, 2023
Review
219 days
Class
Class II
Product code
PPW
Recalls
None
Predicates
1

Its longest line of descent runs back 13 generations to K962603 (1997). 57 ancestors in all, the oldest K891104 (1989). 2 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2016: 1 other ancestor2015: 2 other ancestors2014: 1 other ancestor2013: 3 other ancestors2010: 2 other ancestors2004: 2 other ancestors2001: 4 other ancestors2009: 1 other ancestor2005: 2 other ancestors2003: 3 other ancestors2000: 5 other ancestors1999: 2 other ancestors1996: 3 other ancestors1995: 1 other ancestor1991: 2 other ancestors2012: 1 other ancestor2006: 1 other ancestor1998: 2 other ancestors1994: 1 other ancestor1992: 2 other ancestors2002: 1 other ancestor1993: 1 other ancestor1989: 1 other ancestor2025: 1 descendant cleared2026: 1 descendant clearedK962603 · Masimo Set MS-1 Pulse Oximeter & the Lnop Series of Sensors & Cables · Masimo Corp. · 1997K973887 · Masimo Set MS-1P Pulse Oximeter and the Lnop Series of Sensors and Cables · Masimo Corp. · 1998K982255 · Model 2000 Pulse Oximeter · Ivy Biomedical Systems, Inc. · 1998K991823 · N-395 Pulse Oximeter, Model N-395 · Nellcor Puritan Bennett, Inc. · 1999K012451 · Propaq Encore Models 202, 204, 206; Propaq CS Models 242, 244, 246 · Welch Allyn Protocol, Inc. · 2001K061993 · Equivital, Model EQ-01 · Hidalgo Limited · 2006K081140 · Visensia · Obs Medical · 2008K110953 · Visensia, Visensia with Alert · Obs Medical · 2011K152258 · T3 Software · Etiometry, Inc. · 2016K163065 · T3 Software · Etiometry, Inc. · 2017K190273 · T3 Platform software · Etiometry, Inc. · 2019K202306 · T3 Platform software · Etiometry, Inc. · 2020K213230 · T3 Platform Software · Etiometry, Inc. · 20221990200020102020
  1. Root · 13 generations backK962603 Masimo Set MS-1 Pulse Oximeter & the Lnop Series of Sensors & CablesMasimo Corp. · 1997
  2. 9 generations between
  3. 3 generations backK190273 T3 Platform softwareEtiometry, Inc. · 2019
  4. 2 generations backK202306 T3 Platform softwareEtiometry, Inc. · 2020
  5. 1 generation backK213230 T3 Platform SoftwareEtiometry, Inc. · 2022
  6. This deviceK223578 T3 Platform softwareEtiometry, Inc. · 2023
  7. Descendant · cites it directly · 1 of its ownK241479 Etiometry Platform (DAV 5.4 RAE 9.2)Etiometry, Inc. · 2025
  8. Descendant · 2 generations on · 0 of its ownK254066 Etiometry PlatformEtiometry, Inc. · 2026
Show all 13 generations
  1. Root · 13 generations backK962603 Masimo Set MS-1 Pulse Oximeter & the Lnop Series of Sensors & CablesMasimo Corp. · 1997
  2. 12 generations backK973887 Masimo Set MS-1P Pulse Oximeter and the Lnop Series of Sensors and…Masimo Corp. · 1998
  3. 11 generations backK982255 Model 2000 Pulse OximeterIvy Biomedical Systems, Inc. · 1998
  4. 10 generations backK991823 N-395 Pulse Oximeter, Model N-395Nellcor Puritan Bennett, Inc. · 1999
  5. 9 generations backK012451 Propaq Encore Models 202, 204, 206; Propaq CS Models 242, 244, 246Welch Allyn Protocol, Inc. · 2001
  6. 8 generations backK061993 Equivital, Model EQ-01Hidalgo Limited · 2006
  7. 7 generations backK081140 VisensiaObs Medical · 2008
  8. 6 generations backK110953 Visensia, Visensia with AlertObs Medical · 2011
  9. 5 generations backK152258 T3 SoftwareEtiometry, Inc. · 2016
  10. 4 generations backK163065 T3 SoftwareEtiometry, Inc. · 2017
  11. 3 generations backK190273 T3 Platform softwareEtiometry, Inc. · 2019
  12. 2 generations backK202306 T3 Platform softwareEtiometry, Inc. · 2020
  13. 1 generation backK213230 T3 Platform SoftwareEtiometry, Inc. · 2022
  14. This deviceK223578 T3 Platform softwareEtiometry, Inc. · 2023

Most influential descendants

Showing 2 of 2 · See all
  • K241479Etiometry Platform (DAV 5.4 RAE 9.2)Etiometry, Inc. · 2025 · cites it directly1descendant
  • K254066Etiometry PlatformEtiometry, Inc. · 2026 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−13K962603Masimo Set MS-1 Pulse Oximeter & the Lnop Series of Sensors & CablesMasimo Corp.1997—
−12K973887Masimo Set MS-1P Pulse Oximeter and the Lnop Series of Sensors and CablesMasimo Corp.1998—
−11K982255Model 2000 Pulse OximeterIvy Biomedical Systems, Inc.1998—
−10K991823N-395 Pulse Oximeter, Model N-395Nellcor Puritan Bennett, Inc.1999—
−9K012451Propaq Encore Models 202, 204, 206; Propaq CS Models 242, 244, 246Welch Allyn Protocol, Inc.2001—
−8K061993Equivital, Model EQ-01Hidalgo Limited2006—
−7K081140VisensiaObs Medical2008—
−6K110953Visensia, Visensia with AlertObs Medical2011—
−5K152258T3 SoftwareEtiometry, Inc.2016—
−4K163065T3 SoftwareEtiometry, Inc.2017—
−3K190273T3 Platform softwareEtiometry, Inc.2019—
−2K202306T3 Platform softwareEtiometry, Inc.2020—
−1K213230T3 Platform SoftwareEtiometry, Inc.2022—
0 (this device)K223578T3 Platform softwareEtiometry, Inc.2023—
+1K241479Etiometry Platform (DAV 5.4 RAE 9.2)Etiometry, Inc.2025—
+2K254066Etiometry PlatformEtiometry, Inc.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198910
199120
199220
199310
199410
199510
199630
199820
199920
200050
200140
200210
200330
200420
200520
200610
200910
201020
201210
201330
201410
201520
201610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
202610
FIG. 1 — Lineage of K223578, 1997–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PPW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PPW device

  1. #1 K213230 T3 Platform Softwarescore 15.9 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K213230T3 Platform Software
Summary page 6
…tform™ software featuring the T3 Data Aggregation & Visualization software module version 5.0 and the T3 Risk Analytics Engine software module version 8.0, cleared under K213230. The predicate has not been subject to a design-related recall. No reference devices were used in this submission.…
Etiometry, Inc.2022—

Also cleared against K213230: 2 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K241479Etiometry Platform (DAV 5.4 RAE 9.2)Etiometry, Inc.20251

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 7 companies; a new generation was cleared every 1.6 years on median.
  • 7 of the 57 ancestors have a recall of any class.
  • Of its descendants, K241479 (Etiometry, Inc., 2025) has gone furthest, with 1 descendant of its own.
  • 2 other devices also cite its predicate K213230.

How does its category compare?

All PPW devices

PPW Adjunctive Cardiovascular Status Indicator: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · PPW

2in 2025

2016: 12018: 12022: 22023: 12025: 22026 (partial year): 1
2007high 2 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PPW

Too few PPW 510(k)s in any year since 2007 to give a median.

Recalls per year · PPW

No recall names PPW since 2007.

Adverse event reports per year · PPW

No MAUDE report names PPW since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20161—00
20170—00
20181—00
20190—00
20200—00
20210—00
20222—00
20231—00
20240—00
20252—00
20261—0—

What is it indicated for?

The T3 Platform™ software features the T3 Data Aggregation & Visualization software module version 5.0 and the T3 Risk Analytics Engine software module version 9.0. The T3 Data Aggregation & Visualization software module is intended for the recording and display of multiple physiological parameters of the adult, pediatric, and neonatal patients from supported bedside devices. The software module is not intended for alarm notification or waveform display…

Read the full statement (873 words)

The T3 Platform™ software features the T3 Data Aggregation & Visualization software module version 5.0 and the T3 Risk Analytics Engine software module version 9.0.

The T3 Data Aggregation & Visualization software module is intended for the recording and display of multiple physiological parameters of the adult, pediatric, and neonatal patients from supported bedside devices. The software module is not intended for alarm notification or waveform display, nor is it intended to control any of the independent bedside devices to which it is connected. The software module is intended to be used by healthcare professionals for the following purposes:

• To remotely consult regarding a patient’s status, and

• To remotely review other standard or critical near real-time patient data in order to utilize this information to aid in clinical decisions and deliver patient care in a timely manner.

The T3 Data Aggregation & Visualization software module can display numeric physiologic data captured by other medical devices:

• Airway flow, volume, and pressure

• Arterial blood pressure (invasive and non-invasive, systolic, diastolic, and mean)

• Bispectral index (BIS, signal quality index, suppression ratio)

• Cardiac Index

• Cardiac output

• Central venous pressure

• Cerebral perfusion pressure

• End-tidal CO2

• Heart rate

• Heart rate variability

• Intracranial pressure

• Left atrium pressure

• Oxygen saturation (intravascular, regional, SpO2)

• Premature ventricular counted beats

• Pulmonary artery pressure (systolic, diastolic, and mean)

• Pulse pressure variation

• Pulse Rate

• Respiratory rate

• Right atrium pressure

• Temperature (rectal, esophageal, tympanic, blood, core, nasopharyngeal, skin)

• Umbilical arterial pressure (systolic, diastolic, and mean)

The T3 Data Aggregation & Visualization software module can display laboratory measurements including arterial and venous blood gases, complete blood count, and lactic acid. T3 Data Aggregation & Visualization software module can display information captured by the T3 Risk Analytics Engine software module.

The T3 Risk Analytics Engine software module calculates four indices: the IDO2 Index™ for inadequate delivery of oxygen, the IVCO2 Index™ for inadequate ventilation of carbon dioxide, the ACD Index™ for acidemia, and the HLA Index™ for hyperlactatemia.

The IDO2 Index™ is indicated for use by health care professionals with post-surgical patients 0 to 12 years of age and weighing 2 kg or more under intensive care. The IDO2 Index™ is derived by mathematical manipulations of the physiologic data and laboratory measurements received by the T3 Data Aggregation & Visualization software module. When the IDO2 Index™ is increasing, it means that there is an increasing risk of inadequate oxygen delivery and attention should be brought to the patient. The IDO2 Index™ presents partial quantitative information about the patient's cardiovascular condition, and no therapy or drugs can be administered based solely on the interpretation statements.

The IVCO2 Index™ is indicated for use by health care professionals with invasively ventilated patients 0 to 12 years of age under intensive care. The IVCO2 Index™ is derived by mathematical manipulations of the physiologic data and laboratory measurements received by the T3 Data Aggregation and Visualization software module. When the IVCO2 Index™ is increasing, it means that there is an increasing risk of inadequate carbon dioxide ventilation and attention should be brought to the patient. The IVCO2 Index™ presents partial quantitative information about the patient's respiratory condition, and no therapy or drugs can be administered based solely on the interpretation statements.

The ACD Index™ is indicated for use by health care professionals with invasively ventilated patients 0 to 12 years of age and weighing 2 kg or more under intensive care. The ACD Index™ is derived by mathematical manipulations of the physiologic data and laboratory measurements received by the T3 Data Aggregation and Visualization software module. When the ACD Index™ is increasing, it means that there is an increasing risk of acidemia and attention should be brought to the patient. The ACD Index™ presents partial quantitative information about the patient's respiratory condition, and no therapy or drugs can be administered based solely on the interpretation statements.

The HLA Index™ is indicated for use by health care professionals with post-surgical patients 0 to 12 years of age and weighing 2 kg or more under intensive care. The HLA Index™ is derived by mathematical manipulations of the physiologic data and laboratory measurements received by the T3 Data Aggregation & Visualization software module. When the HLA Index™ is increasing, it means that there is an increasing risk of hyperlactatemia and attention should be brought to the patient. The HLA Index™ presents partial quantitative information about the patient's cardiovascular condition, and no therapy or drugs can be administered based solely on the interpretation statements.

WARNINGS:

• Do not use the T3 Platform software as an active patient monitoring system.

• Do not use the T3 Platform software to replace any part of the hospital's device monitoring.

• Do not rely on the T3 Platform software as the sole source of patient status information.

• Do not use any of the T3 Platform indices as a substitute for taking blood samples.

• The indices present qualitative and potentially imperfect information of the patient's condition and in certain scenarios, the indices may contradict each other. The primary data should be reviewed as part of standard patient evaluations and no decisions should be solely based on the indices.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K223578: T3 Platform software.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K223578

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026